LIVE

TRLV

Trulieve Cannabis Corp.

TRLV

NYSE·Healthcare·Medical - Pharmaceuticals·Mkt cap $1.6B

$9.85

+3.25%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$3.80 - $13.28

P/E

985.00

Fwd P/E

Beta

1.86

Div Yield

0.00%

Avg Vol

969.6K

Shares Out

Mkt Cap

$1.6B

Price action

Price chart

Up 148.4% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

No bull reasons captured for this rating yet.

Bear Case

1 risk

  • Above-average volatility (beta 1.9).

Growth

No forward estimates available

Value

Valuation data unavailable

Momentum

Hot

+58.0% over 3m

Quality

Strong

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 6, 2026

LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

Q1 26

$0.01

Next: Aug 6, 2026

Revenue trend · last 1Q

Q1 26

$286.8M

Margins · last 1Q

Profit

0.8%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

No analyst coverage on file for this stock yet.

vs Industry

How TRLV stacks vs Medical - Pharmaceuticals

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.